Atherothrombotic residual risk in coronary and peripheral artery disease patients on guideline-recommended antiplatelet monotherapy: baseline preliminary results from the RESRISK study

被引:0
|
作者
Vallejo-Vaz, A. [1 ]
Dharmayat, K. I. [1 ]
Nzeakor, N. [2 ]
Fatoba, S. T. [3 ]
McMahon, P. [4 ]
Tolani, E. [4 ]
Carrasco, C. P. [2 ]
Ray, K. K. [1 ]
机构
[1] Imperial Coll London, Sch Publ Hlth, London, England
[2] Bayer Plc, Reading, Berks, England
[3] Bayer AG, Berlin, Germany
[4] IQVIA, London, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2546 / 2546
页数:1
相关论文
共 50 条
  • [1] RESIDUAL RISK OF MAJOR ADVERSE CARDIOVASCULAR AND LIMB EVENTS AMONG DIFFERENT ATHEROSCLEROTIC CARDIOVASCULAR DISEASE PHENOTYPES RECEIVING GUIDELINE-RECOMMENDED ANTIPLATELET MONOTHERAPY: THE RESRISK STUDY
    Vallejo-Vaz, A. J.
    Dharmayat, K. I.
    Nzeakor, N.
    Carrasco, C. P.
    Fatoba, S. T.
    Fonseca, M. J.
    Tolani, E.
    Lee, C.
    Ray, K. K.
    ATHEROSCLEROSIS, 2022, 355 : E62 - E63
  • [2] DO COMORBIDITIES AND RESIDUAL RISK FACTORS INFLUENCE CHOICE OF ANTIPLATELET MONOTHERAPY IN PATIENTS WITH PERIPHERAL ARTERY DISEASE? RESULTS FROM THE CROSS-SECTIONAL RESRISK-PAD STUDY
    Vallejo-Vaz, A. J.
    Dharmayat, K.
    Nzeakor, N.
    Carrasco, C.
    Fatoba, S.
    Fonseca, M.
    Tolani, E.
    Lee, C.
    Ray, K.
    ATHEROSCLEROSIS, 2023, 379 : S194 - S195
  • [3] Understanding adherence to guideline-recommended therapy in patients with peripheral artery disease: A qualitative study
    Lampridou, Smaragda
    Saghdaoui, Layla Bolton
    Reguenga, Maria
    Davies, Alun Huw
    Wells, Mary
    JOURNAL OF VASCULAR NURSING, 2025, 43 (01) : 46 - 54
  • [4] Recurrent cardiovascular and limb events in 294,428 patients with coronary or peripheral artery disease or ischemic stroke on antiplatelet monotherapy: The RESRISK cohort study
    Vallejo-Vaz, Antonio J.
    Dharmayat, Kanika I.
    Nzeakor, Nnanyelu
    Carrasco, Carlos P.
    Fatoba, Samuel T.
    Fonseca, Maria J.
    Tolani, Esther
    Lee, Christopher
    Ray, Kausik K.
    ATHEROSCLEROSIS, 2024, 398
  • [5] Outcomes of Guideline-Recommended Percutaneous Coronary Intervention in Women with Obstructive Coronary Artery Disease: A Longitudinal Cohort Study
    Delamain, Tacianne Rolemberg Braga
    Delamain, Jose Henrique Herrmann
    Braga, Sergio Luiz Navarro
    Costa, Ricardo
    de Siqueira, Dimytri Alexandre Alvim
    Feres, Fausto
    Centemero, Marinella Patrizia
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2025, 122 (01)
  • [6] Multicomponent interventions designed to support adherence to guideline-recommended therapy in patients with peripheral artery disease: A scoping review
    Lampridou, Smaragda
    Domun, Tania
    Rosenberg, Javiera
    Lear, Rachael
    Davies, Alun Huw
    Wells, Mary
    Judah, Gaby
    VASCULAR MEDICINE, 2025,
  • [7] Achievement of guideline-recommended target blood pressure is associated with reducing the risk of hemorrhagic and ischemic stroke in Japanese coronary artery disease patients -the CLIDAS study-
    Oba, Yusuke
    Kabutoya, Tomoyuki
    Kohro, Takahide
    Imai, Yasushi
    Kario, Kazuomi
    Sato, Hisahiko
    Nochioka, Kotaro
    Nakayama, Masaharu
    Akashi, Naoyuki
    Fujita, Hideo
    Mizuno, Yoshiko
    Kiyosue, Arihiro
    Iwai, Takamasa
    Miyamoto, Yoshihiro
    Nakano, Yasuhiro
    Ishii, Masanobu
    Nakamura, Taishi
    Tsujita, Kenichi
    Matoba, Tetsuya
    Nagai, Ryozo
    HYPERTENSION RESEARCH, 2025, 48 (02) : 632 - 639
  • [8] Efficacy of a Guideline-Recommended Risk-Reduction Program to Improve Cardiovascular and Limb Outcomes in Patients With Peripheral Arterial Disease
    Hussain, Mohamad A.
    Al-Omran, Mohammed
    Mamdani, Muhammad
    Eisenberg, Naomi
    Premji, Azra
    Saldanha, Lisa
    Wang, Xuesong
    Verma, Subodh
    Lindsay, Thomas F.
    JAMA SURGERY, 2016, 151 (08) : 742 - 750
  • [9] HIGH USE OF GUIDELINE-RECOMMENDED THERAPIES IN CANADIAN OUTPATIENTS WITH STABLE CORONARY ARTERY DISEASE: INSIGHTS FROM THE PROSPECTIVE OBSERVATIONAL LONGITUDINAL REGISTRY OF PATIENTS WITH STABLE CORONARY ARTERY DISEASE (CLARIFY) REGISTRY
    Gandhi, S.
    Dorian, P.
    Tardif, J. C.
    Steg, P. G.
    Huynh, T.
    Wong, G. C.
    Love, M. P.
    Jervis, K.
    Goodman, S. G.
    CANADIAN JOURNAL OF CARDIOLOGY, 2012, 28 (05) : S390 - S391
  • [10] Survey on patients' perspectives about guideline-recommended disease management for chronic heart failure: results from the VISIT-HF study
    Strohmayer, Katharina
    Wagner, Gernot
    Sommer, Isolde
    Pia, Auersperg
    Lechner-Bracun, Renate
    Moertl, Deddo
    WIENER KLINISCHE WOCHENSCHRIFT, 2019, 131 : 329 - 332